Ionis Pharmaceuticals (IONS) Non-Current Assets (2009 - 2026)

Ionis Pharmaceuticals' Non-Current Assets history runs 18 years deep, the most recent figure standing at $503.2 million for Q2 2026.

• In Q2 2026, Non-Current Assets rose 23.35% year-over-year to $503.2 million; the TTM figure through Jun 2026 stood at $2.1 billion (up 32.91% YoY), while the FY2025 annual figure was $533.2 million, up 39.08% from the prior year.
• Non-Current Assets for Q2 2026 stood at $503.2 million, down from $513.0 million in the prior quarter.
• The five-year high for Non-Current Assets was $533.2 million in Q4 2025, with the low at $265.0 million in Q2 2022.
• The 5-year median for Non-Current Assets is $358.1 million (2023), against an average of $380.7 million.
• The sharpest annual moves came in 2024 and 2025: Non-Current Assets increased 1.65% in 2024, then surged 39.99% in 2025.
• Ionis Pharmaceuticals' Non-Current Assets stood at $331.2 million in 2022, then gained by 5.14% to $348.2 million in 2023, then grew by 10.1% to $383.4 million in 2024, then jumped by 39.08% to $533.2 million in 2025, then fell by 5.62% to $503.2 million in 2026.
• Business Quant data shows IONS's Non-Current Assets at $503.2 million in Q2 2026, $513.0 million in Q1 2026, and $533.2 million in Q4 2025.